Find in Library

Somatic copy number alterations (SCNAs) are frequently observed in high-grade ovarian serous carcinoma (HGOSC). However, their impact on gene expression levels has not been systematically assessed. In this study, we explored the relationship between recurrent SCNA and gene expression using The Cancer Genome Atlas Pan Cancer dataset (OSC, TCGA, PanCancer Atlas) to identify cancer-related genes in HGOSC. We then investigated any association between highly correlated cancer genes and clinicopathological parameters, including age of diagnosis, disease stage, overall survival (OS), and progression-free survival (PFS). A total of 772 genes with recurrent SCNAs were observed. SCNA and mRNA expression levels were highly correlated for 274 genes; 24 genes were classified as a Tier 1 gene in the Cancer Gene Census in the Catalogue of Somatic Mutations in Cancer (CGC-COSMIC). Of these, 11 Tier 1 genes had highly correlated SCNA and mRNA expression levels: <i>TBL1XR1</i>, <i>PIK3CA</i>, <i>UBR5</i>, <i>EIF3E</i>, <i>RAD21</i>, <i>EXT1</i>, <i>RECQL4</i>, <i>KRAS</i>, <i>PRKACA</i>, <i>BRD4</i>, and <i>TPM4</i>. There was no association between gene amplification and disease stage or PFS. <i>EIF3E</i>, <i>RAD21</i>, and <i>EXT1</i> were more frequently amplified in younger patients, specifically those under the age of 55 years. Patients with tumors carrying <i>PRKACA</i>, <i>BRD4</i>, or <i>TPM4</i> amplification were associated with a significantly shorter OS. <i>RECQL4</i> amplification was more frequent in younger patients, and tumors with this amplification were associated with a significantly better OS.